Company Filing History:
Years Active: 2011
Title: The Innovations of Marcus Schultze-Mosgau
Introduction
Marcus Schultze-Mosgau is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of progesterone receptor antagonists. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.
Latest Patents
One of Marcus Schultze-Mosgau's key patents is related to progesterone receptor antagonists. The patent describes compounds of general formula I, where R1 can be a hydrogen atom and R2 a hydroxyl group, or R1 and R2 together can form an oxo group. This invention represents a significant advancement in the understanding and application of progesterone receptor modulation.
Career Highlights
Marcus Schultze-Mosgau is associated with Bayer Schering Pharma AG, a leading global pharmaceutical company. His role at Bayer has allowed him to work on cutting-edge research and development projects, contributing to the company's reputation for innovation in the healthcare sector.
Collaborations
He has collaborated with esteemed colleagues such as Ulrike Fuhrmann and Anja Schmidt. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations.
Conclusion
Marcus Schultze-Mosgau exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of progesterone receptor antagonists, highlight the importance of research and collaboration in advancing medical science.